SESAME for Septal Reduction
Presenter
Adam Greenbaum, M.D., Emory Heart & Vascular Center at Decatur, Atlanta, GA
Adam Greenbaum, M.D., Emory Heart & Vascular Center at Decatur, Atlanta, GA
Learning Objectives:
- Discuss indications for septal reduction therapy in setting of TMVR
- Describe theoretical advantages of SESAME compared with alcohol septal ablation
- Review technical aspects and early outcomes of SESAME
Keywords: Structural Heart Disease (SHD)